Matthew Gillmor CFA
Stock Analyst at KeyBanc
(0.95)
# 3,957
Out of 5,004 analysts
127
Total ratings
51.3%
Success rate
-2.3%
Average return
Main Sectors:
Stocks Rated by Matthew Gillmor CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMRI Lumexa Imaging Holdings | Initiated Coverage: Buy | $18 | $10.21 | +76.30% | 1 | Sep 25, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $147 | $123.47 | +19.06% | 13 | Sep 17, 2026 | |
| INNV InnovAge Holding | Reiterated: Buy | $13 → $14 | $9.00 | +55.56% | 8 | Sep 9, 2026 | |
| SGRY Surgery Partners | Reiterated: Hold | n/a | $14.40 | - | 6 | Aug 11, 2026 | |
| EVH Evolent Health | Reiterated: Hold | n/a | $3.61 | - | 8 | Aug 10, 2026 | |
| ASTH Astrana Health | Reiterated: Hold | n/a | $36.37 | - | 5 | Aug 7, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $80 | $56.59 | +41.37% | 8 | Aug 3, 2026 | |
| ALHC Alignment Healthcare | Reiterated: Buy | $28 | $8.21 | +241.05% | 8 | Jul 31, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Buy | $40 | $28.09 | +42.40% | 10 | Jul 30, 2026 | |
| HUM Humana | Reiterated: Hold | n/a | $397.93 | - | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $475 → $435 | $435.61 | -0.14% | 13 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $475 | $376.59 | +26.13% | 12 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.54 | - | 9 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $113.19 | - | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $225 | $259.71 | -13.36% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $70.79 | +29.96% | 2 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.71 | - | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $178.86 | - | 3 | Oct 28, 2025 |
Lumexa Imaging Holdings
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $10.21
Upside: +76.30%
Encompass Health
Sep 17, 2026
Reiterated: Buy
Price Target: $147
Current: $123.47
Upside: +19.06%
InnovAge Holding
Sep 9, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $9.00
Upside: +55.56%
Surgery Partners
Aug 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.40
Upside: -
Evolent Health
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.61
Upside: -
Astrana Health
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $36.37
Upside: -
BrightSpring Health Services
Aug 3, 2026
Reiterated: Buy
Price Target: $80
Current: $56.59
Upside: +41.37%
Alignment Healthcare
Jul 31, 2026
Reiterated: Buy
Price Target: $28
Current: $8.21
Upside: +241.05%
Acadia Healthcare Company
Jul 30, 2026
Reiterated: Buy
Price Target: $40
Current: $28.09
Upside: +42.40%
Humana
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $397.93
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: $475 → $435
Current: $435.61
Upside: -0.14%
Jul 14, 2026
Reiterated: Buy
Price Target: $400 → $475
Current: $376.59
Upside: +26.13%
Jun 3, 2026
Reiterated: Hold
Price Target: n/a
Current: $10.54
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $113.19
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $250 → $225
Current: $259.71
Upside: -13.36%
Apr 29, 2026
Reiterated: Buy
Price Target: $92
Current: $70.79
Upside: +29.96%
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.71
Upside: -
Oct 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $178.86
Upside: -